LPD-608

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameLPD-608
Drug Alias Namesecond-generation cholesterol absorption/beta-lactamase inhibitors (Lipideon Biotechnology)LPD-608
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionBeta Lactamase inhibitorsCholesterol modulators
TargetsBeta LactamaseCholesterol
Therapy Area/IndicationsHypercholesterolemia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySwitzerland
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesLipideon Biotechnology AG
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesLipideon Biotechnology AG
Active IndicationsN/A
Inactive IndicationsHypercholesterolemia

Other Information

ATC CodeN/A
Related LinksN/A